Veeva Systems Inc banner

Veeva Systems Inc
F:VEE

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
F:VEE
Watchlist
Price: 173.45 EUR 1.61% Market Closed
Market Cap: €28B

Veeva Systems Inc
Investor Relations

Veeva Systems makes cloud software for companies in pharmaceuticals, biotechnology, and medical devices. Its tools help customers manage drug sales, clinical trials, regulatory documents, quality records, and safety data. Instead of selling broad business software, Veeva focuses on the tightly regulated life sciences market, where companies need systems built around compliance and traceability. The company sells its products mainly as subscriptions, with some professional services to help customers set them up and connect them to existing systems. Its main customers are drug makers, biotech firms, and medtech companies, along with some partners in the wider life sciences supply chain. These customers use Veeva’s software to run key work processes across research, development, and commercial operations. What sets Veeva apart is its deep specialization. Life sciences companies face strict rules, long product cycles, and heavy documentation needs, so they often prefer software built specifically for that environment rather than generic enterprise tools. That makes Veeva an important software layer in the industry, sitting between the companies that develop medicines and the teams that bring those products to market.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2027
Call Date
Jun 3, 2026
AI Summary
Q1 2027

Beat: Veeva said fiscal Q1 results came in ahead of guidance, with total revenue of $883 million and operating income of $395 million.

AI push: Management spent most of the call explaining Falcon, its new agentic labor platform, which it sees as a disruptive new market rather than a tool for customer customization.

CRM strength: Vault CRM continues to win share, with over 150 customers live, more than 40 migrations completed, and an overall win rate above 80%.

Crossix: Crossix remained strong, helped by a healthy digital ad market and new product innovation around channels like OpenEvidence and Meta.

Ostro: Veeva framed Ostro as a strategic commercial engagement platform and said it should add about $10 million in the remaining 3 quarters of the year.

Guidance: Management said the macro backdrop is unchanged and that guidance already reflects current conditions; it also raised full-year commercial subscription revenue by $15 million, with about 2/3 tied to Ostro.

Key Financials
Revenue
$883 million
Operating income
$395 million
Ostro contribution
about $10 million
Commercial CRM customers live
over 150 customers
CRM migrations
over 40 migrations
CRM win rate
over 80%
Top-20 CRM decisions remaining
4 decisions
Services quarter
record quarter
Crossix customers
not specified
Margins
Q1 EBIT margin 45%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Peter P. Gassner
Founder, CEO & Director

Peter P. Gassner is a prominent figure in the technology and life sciences industries, best known as the co-founder and CEO of Veeva Systems Inc. Veeva Systems is a cloud-computing company focused on providing software solutions for the global life sciences industry. Under Gassner's leadership, the company has become a major player in the sector, known for its innovation and customer-centric approach. Gassner began his career in software development, working at IBM and later at Oracle, where he contributed significantly to the growth of their CRM division. His stint at Oracle honed his skills in enterprise software development and management, laying the groundwork for his future ventures. Before founding Veeva in 2007, Gassner also worked at Salesforce, where he was responsible for building the original technology team and was instrumental in developing the company’s platform. His strategic vision for Veeva Systems has always emphasized deep industry focus, product excellence, and customer success, which have been key factors in the company's expansion and efficacy. Under his guidance, Veeva has consistently grown its product offering, which includes applications for clinical trial management, regulatory compliance, quality management, and other areas critical to life sciences and pharmaceuticals. Peter Gassner's leadership style and business acumen have been widely recognized, earning him numerous accolades in the tech world. He is also known for advocating a genuine employee-centric culture and maintaining high standards of ethical business practices. Through his work with Veeva, Gassner has played a crucial role in transforming how pharmaceutical and biotech companies operate, ultimately aiming to improve patient outcomes globally.

Mr. Thomas D. Schwenger
President & Chief Customer Officer

Thomas D. Schwenger is a notable executive at Veeva Systems Inc., a cloud-computing company focused on the life sciences industry. As Chief Commercial Officer, he takes on the pivotal role of overseeing the company’s customer success and market expansion strategies. With a customer-centric approach, Schwenger is responsible for driving the company’s go-to-market functions including sales, services, and marketing. Before joining Veeva, Thomas Schwenger held several leadership roles that equipped him with extensive experience in managing large-scale operations and leading high-performance teams. He was previously affiliated with top-tier professional services firms, where he developed a strong foundation in strategic consulting and enterprise software solutions. Schwenger's educational background includes a focus on business and technology, which complements his professional experience in offering innovative solutions that align technology with business needs. His leadership at Veeva Systems is marked by a commitment to excellence and a drive to enhance the company’s value proposition to the life sciences sector. Through his strategic insights, Schwenger plays a crucial role in shaping the company's future trajectory and sustaining its competitive edge in the market.

Mr. Brian Van Wagener
Chief Financial Officer
No Bio Available
Ms. Kristine B. Diamond
Principal Accounting Officer
No Bio Available
Mr. Matthew Robinson
Chief Technology Officer
No Bio Available
Mr. Pinal Patel
Chief Information Officer
No Bio Available
Mr. Gunnar Georg Hansen
Director of Investor Relations
No Bio Available
Mr. Jonathan W. Faddis J.D.
Senior VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Jacques Mourrain Ph.D.
Vice President of Quality, Regulatory & Compliance
No Bio Available
Ms. Vivian Welsh
Chief People Officer
No Bio Available

Contacts

Address
CALIFORNIA
Pleasanton
4280 Hacienda Dr
Contacts
+19252648887.0
www.veeva.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett